Skip to main content
PMC home page
CNS Drug Reviews logoLink to CNS Drug Reviews
. 2006 Aug 29;12(2):113–122. doi: 10.1111/j.1527-3458.2006.00113.x

Humanin and Colivelin: Neuronal‐Death‐Suppressing Peptides for Alzheimer's Disease and Amyotrophic Lateral Sclerosis

Masaaki Matsuoka 1,✉, Yuichi Hashimoto 1, Sadakazu Aiso 2, Ikuo Nishimoto 1
PMCID: PMC6494132  PMID: 16958985

ABSTRACT

Humanin (HN), a 24‐amino‐acid neuroprotective peptide, was originally found in the occipital lobe of an autopsied Alzheimer's disease (AD) patient. HN inhibits neuronal death by binding to its specific receptor on the cell membrane and triggering a Jak2/STAT3 prosurvival pathway. The activation of this pathway may represent a therapeutic approach to AD. HN also exhibits neuroprotective activity against toxicity by familial amyotrophic lateral sclerosis (ALS)‐related mutant superoxide dismutase (SOD1). Recent investigations established that AGA‐(C8R)‐HNG17, a 17‐amno‐acid derivative of HN, is 105 times more potent as a neuroprotective than HN; at 10‐picomolar and higher concentrations in vitro it completely suppresses neuronal death. Moreover, a 26‐amino‐acid peptide colivelin (CL), composed of activity‐dependent neurotrophic factor (ADNF) C‐terminally fused to AGA‐(C8R)‐HNG17, provides complete neuroprotection at 100‐femtomolar or higher concentrations in vitro. A series of experiments using mouse AD and ALS models further established the efficacy of HN derivatives, including CL, against these diseases in vivo. HN and CL can be viewed as drug candidates for neuronal death suppression therapy in AD or ALS.

Keywords: Alzheimer's disease, Amyotrophic lateral sclerosis, β‐Amyloid, Colivelin, Humanin

Full Text

The Full Text of this article is available as a PDF (130.0 KB).

REFERENCES

  • 1. Brenneman DE, Gozes I. A femtomolar‐acting neuroprotective peptide. J Clin Invest 1996;97: 2299–2307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Bruijn LI, Miller TM, Cleveland DW. U. Annu Rev Neurosci 2004;27: 723–749. [DOI] [PubMed] [Google Scholar]
  • 3. Caricasole A, Bruno V, Cappuccio I, Melchiorri D, Copani A, Nicoletti F. A novel rat gene encoding a humanin‐like peptide endowed with broad neuroprotective activity. FASEB J 2002; 16: 1331–1333. [DOI] [PubMed] [Google Scholar]
  • 4. Chiba T, Hashimoto Y, Tajima H et al. N in vivo. J Neurosci Res 2004;78: 542–552. [DOI] [PubMed] [Google Scholar]
  • 5. Chiba T, Yamada M, Hashimoto Y et al. D in vivo. J Neurosci 2005;25: 10252–10261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Chiba T, Yamada M, Sasabe J, et al. Colivelin prolongs survival of an ALS model mouse. Biochem Biophys Res Commun 2006;343: 793–798. [DOI] [PubMed] [Google Scholar]
  • 7. Cleveland DW, Rothstein JD. F. Nat Rev Neurosci 2001;2: 806–819. [DOI] [PubMed] [Google Scholar]
  • 8. Czech C, Lesort M, Tremp G, et al. Characterization of human presenilin 1 transgenic rats: Increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience 1998;87: 325–336. [DOI] [PubMed] [Google Scholar]
  • 9. Giovanni A, Wirtz‐Brugger F, Keramaris E, Slack R, Park DS. Involvement of cell cycle elements, cyclin‐dependent kinases, pRb, and E2F·DP, in β;‐amyloid‐induced neuronal death. J Biol Chem 1999; 274: 19011–19016. [DOI] [PubMed] [Google Scholar]
  • 10. Gschwind M, Huber G. Apoptotic cell death induced by β‐amyloid 1–42 peptide is cell type dependent. J Neurochem 1995;65: 292–300. [DOI] [PubMed] [Google Scholar]
  • 11. Guo Q, Fu W, Sopher BL, et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin‐1 mutant knock‐in mice. Nat Med 1999;5: 101–106. [DOI] [PubMed] [Google Scholar]
  • 12. Guo B, Zhai D, Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003;423: 456–461. [DOI] [PubMed] [Google Scholar]
  • 13. Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001;29: 166–173. [DOI] [PubMed] [Google Scholar]
  • 14. Harada M, Habata Y, Hosoya M, et al. N‐Formylated humanin activates both formyl peptide receptor‐like 1 and 2. Biochem Biophys Res Commun 2004;324: 255–261. [DOI] [PubMed] [Google Scholar]
  • 15. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002;297: 353–356. [DOI] [PubMed] [Google Scholar]
  • 16. Hashimoto Y, Niikura T, Ito Y, Nishimoto I. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J Biol Chem 2000;275: 34541–34551. [DOI] [PubMed] [Google Scholar]
  • 17. Hashimoto Y, Niikura T, Tajima H, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc Natl Acad Sci USA 2001;98: 6336–6341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Hashimoto Y, Kaneko Y, Tsukamoto E, et al. Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid‐beta peptides via p75NTR/([A‐Z])LAIDD. J Neurochem 2004;90: 549–558. [DOI] [PubMed] [Google Scholar]
  • 19. Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M. Involvement of tyrosine kinases and STAT3 in Humanin‐mediated neuroprotection. Life Sci 2005;77: 3092–3104. [DOI] [PubMed] [Google Scholar]
  • 20. Hashimoto Y, Chiba T, Yamada M, et al. Transforming growth factor beta2 is a neuronal death‐inducing ligand for amyloid‐beta precursor protein. Mol Cell Biol 2005;25: 9304–9317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Hashimoto Y, Nawa M, Chiba T, Aiso S, Nishimoto I, Matsuoka M. Transforming growth factor beta2 autocrinally mediates neuronal cell death induced by amyloid‐beta. J Neurosci Res 2006;83: 1039–1047. [DOI] [PubMed] [Google Scholar]
  • 22. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S. Suppression of mitochondrial succinate dehydrogenase, a primary target of β‐amyloid, and its derivative racemized at Ser residue. J Neurochem 1995;65: 2585–2593. [DOI] [PubMed] [Google Scholar]
  • 23. Kanekura K, Hashimoto Y, Kita Y, et al. A Rac1/([a‐z])hosphatidylinositol 3‐kinase/([a‐z])kt3 anti‐apoptotic pathway, triggered by Alsin LF, the product of the ALS2 gene, antagonizes Cu/([a‐z])n‐superoxide dismutase (SOD1) mutant‐induced motoneuronal cell death. J Biol Chem 2005;280: 4532–4543. [DOI] [PubMed] [Google Scholar]
  • 24. Kanekura K, Hashimoto Y, Niikura T, Aiso S, Matsuoka M, Nishimoto I. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J Biol Chem 2004;279: 19247–19256. [DOI] [PubMed] [Google Scholar]
  • 25. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S. Humanin inhibits cell death of serum‐deprived PC12h cells. Neuroreport 2002;13(6):903–907. [DOI] [PubMed] [Google Scholar]
  • 26. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF‐1 prolongs survival in a mouse ALS model. Science 2003;301: 839–842. [DOI] [PubMed] [Google Scholar]
  • 27. Kawasumi M, Hashimoto Y, Chiba T, et al. Molecular mechanisms for neuronal cell death by Alzheimer's amyloid precursor protein‐relevant insults. Neuro Signals 2002; 11: 236–250. [DOI] [PubMed] [Google Scholar]
  • 28. Krejcova G, Patocka J, Slaninova J. Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 2004;10: 636–639. [DOI] [PubMed] [Google Scholar]
  • 29. Lane RM, Kivipelto M, Greig NH. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin Neuropharmacol 2004;27: 141–149. [DOI] [PubMed] [Google Scholar]
  • 30. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by β‐amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993;90: 7951–7955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Luciano F, Zhai D, Zhu X, et al. Cytoprotective peptide humanin binds and inhibits proapoptotic Bcl‐2/([A‐Z])ax family protein BimEL. J Biol Chem 2005. 280: 15825–15835. [DOI] [PubMed] [Google Scholar]
  • 32. Luo JJ, Wallace W, Riccioni T, et al. Death of PC12 cells and hippocampal neurons induced by adenoviral‐mediated FAD human amyloid precursor protein gene expression. JNeurosci Res 1999;55: 629–642. [DOI] [PubMed] [Google Scholar]
  • 33. Mamiya T, Ukai M. [Gly(14)]‐Humanin improved the learning and memory impairment induced by scopol‐amine in vivo. Br J Pharmacol 2001;134: 1597–1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Niikura T, Yamada M, Chiba T, Aiso S, Matsuoka M, Nishimoto I. Characterization of V642I‐A6421PP‐in‐duced cytotoxicity in primary neurons. J Neurosci Res 2004;77: 54–62. [DOI] [PubMed] [Google Scholar]
  • 35. Niikura T, Chiba T, Aiso S, Matsuoka M, Nishimoto I. Humanin: After the discovery. Mol Neurobiol 2004; 30: 327–340. [DOI] [PubMed] [Google Scholar]
  • 36. Nishimoto I, Matsuoka M, Niikura T. Unravelling the role of humanin. Trends Mol Med 2004;10: 102–105. [DOI] [PubMed] [Google Scholar]
  • 37. Nishimura I, Uetsuki T, Dani SU, et al. D egeneration in vivo of rat hippocampal neurons by wild‐type Alzheimer amyloid precursor protein overexpressed by adenovirus‐mediated gene transfer. J Neurosci 1998; 18: 2387–2398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Pike CJ, Ramezan‐Arab N, Cotman CW. A β‐amyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants. J Neurochem 1997;69: 1601–1611. [DOI] [PubMed] [Google Scholar]
  • 39. Sponne I, Fifre A, Koziel V, Kriem B, Oster T, Pillot T. Humanin rescues cortical neurons from prion‐peptide‐induced apoptosis. Mol Cell Neurosci 2004;25: 95–102. [DOI] [PubMed] [Google Scholar]
  • 40. Storkebaum ED, Lambrechts M, Dewerchin MP, et al. Treatment of motoneuron degeneration by intracere‐broventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 2005;8: 85–92. [DOI] [PubMed] [Google Scholar]
  • 41. Sudo H, Hashimoto Y, Niikura T, et al. Secreted Aβ does not mediate neurotoxicity by antibody‐stimulated amyloid precursor protein. Biochem Biophys Res Commun 2001;282: 548–556. [DOI] [PubMed] [Google Scholar]
  • 42. Tajima H, Kawasumi M, Chiba T, et al. A humanin derivative, S14G‐HN, prevents amyloid‐beta‐induced memory impairment in mice. J Neurosci Res 2005;79: 714–723. [DOI] [PubMed] [Google Scholar]
  • 43. Terashita K, Hashimoto Y, Niikura T, et al. Two serine residues distinctly regulate the rescue function of humanin, an inhibiting factor of Alzheimer's disease‐related neurotoxicity: Functional potentiation by isomerization and dimerization. J Neurochem 2003;85: 1521–1538. [DOI] [PubMed] [Google Scholar]
  • 44. Tsukamoto E, Hashimoto Y, Kanekura K, Niikura T, Aiso S, Nishimoto I. Characterization of the toxic mechanism triggered by Alzheimer's amyloid‐â peptides via p75 neurotrophin receptor in neuronal hybrid cells. J Neurosci Res 2003;73: 627–636. [DOI] [PubMed] [Google Scholar]
  • 45. Vande Velde C, Cleveland DW. VEGF: Multitasking in ALS. Nat Neurosci 2005;8: 5–7. [DOI] [PubMed] [Google Scholar]
  • 46. Weihl CC, Ghadge GD, Kennedy SG, Hay N, Miller RJ, Roos RP. Mutant presenilin‐1 induces apoptosis and downregulates Akt/([a‐z])KB. J Neurosci 1999; 19: 5360–5369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Wolozin B, Iwasaki K, Vito P, et al. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science 1996;274: 1710–1713. [DOI] [PubMed] [Google Scholar]
  • 48. Yamagishi Y, Hashimoto Y, Niikura T, Nishimoto I. Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease‐relevant insults. Peptides 2003;24: 585–595. [DOI] [PubMed] [Google Scholar]
  • 49. Yamatsuji T, Matsui T, Okamoto T, et al. G protein‐mediated neuronal DNA fragmentation induced by familial Alzheimer's disease‐associated mutants of APP. Science 1996;272: 1349–1352. [DOI] [PubMed] [Google Scholar]
  • 50. Yamatsuji T, Okamoto T, Takeda S, Murayama Y, Tanaka N, Nishimoto I. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait‐linked phenotype. EMBO J 1996; 15: 498–509. [PMC free article] [PubMed] [Google Scholar]
  • 51. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine‐nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001;29: 160–165. [DOI] [PubMed] [Google Scholar]
  • 52. Yankner BA, Dawes LR, Fisher S, Villa‐Komaroff L, Oster‐Granite, ML Neve, RL Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989;245: 417–420. [DOI] [PubMed] [Google Scholar]
  • 53. Ying G, Iribarren P, Zhou Y, et al. Humanin, a newly identified neuroprotective factor, uses the G protein‐coupled formylpeptide receptor‐like‐1 as a functional receptor. J Immunol 2004;172: 7078–7085. [DOI] [PubMed] [Google Scholar]
  • 54. Zhao B, Chrest FJ, Horton, WE , Sisodia SS, Kusiak JW. Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J Neurosci Res 1997;47: 253–263. [PubMed] [Google Scholar]

Articles from CNS Drug Reviews are provided here courtesy of Wiley

RESOURCES